World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
35177
World Ranking
13930
National Ranking
7070

Overview

Daniel W. Lin is affiliated with the University of Washington in the United States. Their research primarily focuses on the field of Medicine, with specific subfields including Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology, and Cancer Research. Within these areas, Lin's work concentrates on topics related to prostate and urinary cancers, cancer metabolism, and health system evaluations.

Lin has contributed extensively to the literature on prostate cancer diagnosis, treatment, and management, reflecting substantial engagement with both clinical and research communities. Their research topics include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Cancer, Lipids, and Metabolism
  • Urinary and Genital Oncology Studies
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life

Lin has published numerous papers in leading journals, with recent publications including:

  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management (2022, The Journal of Urology)
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening (2023, The Journal of Urology)
  • Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 (2020, Journal of Clinical Oncology)
  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up (2022, The Journal of Urology)
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy (2023, The Journal of Urology)

The venues where Lin frequently publishes reflect their focus on urologic and oncologic research. These include:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Urologic Oncology Seminars and Original Investigations
  • European Urology
  • JAMA Oncology

Lin's collaborative work involves multiple frequent coauthors, further supporting interdisciplinary research efforts. Notable coauthors include:

  • Peter S. Nelson
  • Jonathan L. Wright
  • George R. Schade
  • Lisa F. Newcomb
  • Heather H. Cheng

Best Publications

  • Circulating microRNAs as stable blood-based markers for cancer detection

    Patrick S. Mitchell;Rachael K. Parkin;Evan M. Kroh;Brian R. Fritz;Brian R. Fritz

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

    Elahe A. Mostaghel;Stephanie T. Page;Daniel W. Lin;Ladan Fazli

  • Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

    Gladell P. Paner;Walter M. Stadler;Donna E. Hansel;Rodolfo Montironi

  • A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

    Dipen J. Parekh;Sanoj Punnen;Daniel D. Sjoberg;Scott W. Asroff

  • Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    Mark K. Buyyounouski;Peter L. Choyke;Jesse K. McKenney;Oliver Sartor

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

    Timothy Gilligan;Daniel W. Lin;Rahul Aggarwal;David Chism

  • Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity

    Stacia K. Wyman;Emily C. Knouf;Emily C. Knouf;Rachael K. Parkin;Brian R. Fritz;Brian R. Fritz

  • A molecular correlate to the Gleason grading system for prostate adenocarcinoma

    Lawrence True;Ilsa Coleman;Sarah Hawley;Ching Ying Huang

  • Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania

    Mauricio Tohen;Ludmila Kryzhanovskaya;Gabrielle Carlson;Melissa DelBello

  • Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

    Mark P. Labrecque;Ilsa M. Coleman;Lisha G. Brown;Lawrence D. True

  • Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer

    John T. Wei;Ziding Feng;Alan W. Partin;Elissa Brown

  • Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

    Sherri M. Donat;Mireya Diaz;Jay Todd Bishoff;Jonathan A. Coleman

  • Castration-Resistant Prostate Cancer: AUA Guideline

    Michael S. Cookson;Bruce J. Roth;Philipp Dahm;Christine Engstrom

  • Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines

    Robert J. Motzer;Eric Jonasch;Neeraj Agarwal;Clair Beard

  • The role of lineage plasticity in prostate cancer therapy resistance

    Himisha Beltran;Andrew Hruszkewycz;Howard I. Scher;Jeffrey Hildesheim

  • The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy

    Jonathan L. Wright;Daniel W. Lin;Michael P. Porter

  • Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

    Robert J. Motzer;Eric Jonasch;Shawna Boyle;Maria I. Carlo

Frequent Co-Authors

Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Lawrence D. True
Lawrence D. True University of Washington
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Martin E. Gleave
Martin E. Gleave University of British Columbia
James D. Brooks
James D. Brooks Stanford University
Ziding Feng
Ziding Feng Fred Hutchinson Cancer Research Center
Matthew R. Cooperberg
Matthew R. Cooperberg University of California, San Francisco
Adam S. Kibel
Adam S. Kibel Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA can involve a variety of pathways beyond the traditional MD or DO route. Many students choose to start with supporting fields or seek graduate opportunities that allow for greater flexibility and affordability. For example, online healthcare administration programs prepare graduates for vital roles managing medical facilities, without the need for a clinical background.

Pursuing advanced leadership roles? The cheapest mha programs online healthcare provide a cost-effective way to earn a Master's in Health Administration, opening doors to high-level management in hospitals and health systems.

For nurses aiming to move into top clinical or academic roles, the cheapest dnp programs online offer affordable options to achieve a Doctor of Nursing Practice degree. If pharmacy interests you, online pharmacist programs enable you to advance your career with the flexibility of remote study.

Each of these online degrees offers unique career possibilities in the medical field. They provide diverse entry points, making it possible for more students to find rewarding roles in healthcare.

Best Scientists Citing Daniel W. Lin

Trending Scientists